Golden West Diagnostics, LLC (GWD) is recognized for its expertise in the in-vitro diagnostic industry. Founded in 2015 as a subsidiary of Golden West Biologicals, Inc., it has leveraged a foundation established since 1989 and holds an ISO 13485:2016 certification since 2015. This places GWD in a strong strategic position as a manufacturer of high-quality components essential for research and further manufacturing.
With a product line that includes the flagship Mass Spect Gold featuring ultra-low analyte matrices, GWD caters to advanced needs in vitamins, steroids, hormones, and toxicology testing. Approximately 60% of their business comes from custom OEM solutions, showcasing their flexibility and commitment to tailored, cost-effective offerings.
As a prominent player in Biotechnology and Life Sciences, headquartered in the United States, Golden West Diagnostics, LLC is a trusted partner delivering exceptional value without recent funding rounds. Their dedication to innovation makes them a compelling consideration for investors seeking robust growth in diagnostic solutions.